Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA(®) Dry Powder Inhaler (original) (raw)

Inspiratory Flow Parameters Through Dry Powder Inhalers in Healthy Volunteers and Patients with Chronic Obstructive Pulmonary Disease (COPD): Device Resistance Does Not Limit Use in COPD

Aino Takala

International Journal of Chronic Obstructive Pulmonary Disease

View PDFchevron_right

Influence of Peak Inspiratory Flow Rates and Pressure Drops on Inhalation Performance of Dry Powder Inhalers

Tomoyuki Okuda

Chemical and Pharmaceutical Bulletin, 2012

View PDFchevron_right

Peak Inspiratory Flow Measured at Different Inhaler Resistances in Patients with Asthma

Eddie McKnight

The Journal of Allergy and Clinical Immunology: In Practice, 2021

View PDFchevron_right

Understanding Dry Powder Inhalers: Key Technical and Patient Preference Attributes

Will Carroll

Advances in Therapy

View PDFchevron_right

Inspiratory flow profile and usability of the NEXThaler, a multidose dry powder inhaler, in asthma and COPD

Sara Barile

BMC Pulmonary Medicine, 2021

View PDFchevron_right

In Vitro Dosing Performance of the ELLIPTA(®) Dry Powder Inhaler Using Asthma and COPD Patient Inhalation Profiles Replicated with the Electronic Lung (eLung™)

Melanie Hamilton

Journal of aerosol medicine and pulmonary drug delivery, 2015

View PDFchevron_right

The Confusing World of Dry Powder Inhalers: It Is All About Inspiratory Pressures, Not Inspiratory Flow Rates

Rajiv Dhand

Journal of Aerosol Medicine and Pulmonary Drug Delivery, 2019

View PDFchevron_right

[Patient preference in the choice of dry powder inhalers]

Joaquín Sanchis

2004

View PDFchevron_right

Multivariate Analysis of Effects of Asthmatic Patient Respiratory Profiles on the In Vitro Performance of a Reservoir Multidose and a Capsule-Based Dry Powder Inhaler

Diego Copelli

Pharmaceutical Research, 2015

View PDFchevron_right

Spirometry Measurement of Peak Inspiratory Flow Identifies Suboptimal Use of Dry Powder Inhalers in Ambulatory Patients with COPD

Alexander Duarte

Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation

View PDFchevron_right

Impact of human behavior on inspiratory flow profiles in patients with pulmonary arterial hypertension using AOS™ dry powder inhaler device

Jeffry Weers

Pulmonary Circulation

View PDFchevron_right

Factors associated with health status and exacerbations in COPD maintenance therapy with dry powder inhalers

Ioanna Tsiligianni

npj Primary Care Respiratory Medicine

View PDFchevron_right

Assessment of inhalation flow patterns of soft mist inhaler co-prescribed with dry powder inhaler using inspiratory flow meter for multi inhalation devices

Hiroyoshi Koide

PLOS ONE, 2018

View PDFchevron_right

Assessment of patterns of use of Dry powder inhaler (DPI), pressurized Metered dose inhaler (MDI), Nebulizer, DPI with MDI, DPI with Nebulizer, MDI with Nebulizer and the combination of DPI, MDI and Nebulizer, in patients with Asthma, Chronic obstructive

Fahad Abdullah

International Journal of Research in Pharmacology & Pharmacotherapeutics, 2018

View PDFchevron_right

Use of dry powder inhalers in acute exacerbations of asthma and COPD

Olof Selroos

Therapeutic Advances in Respiratory Disease, 2009

View PDFchevron_right

Clinical recommendations for dry powder inhaler use in the management of COPD in primary care

Ioanna Tsiligianni

npj Primary Care Respiratory Medicine

View PDFchevron_right

Rational design of a dry powder inhaler: device design and optimisation

Hartwig Steckel

Journal of Pharmacy and Pharmacology, 2012

View PDFchevron_right

Inspiratory Flows and Volumes in Subjects with Cystic Fibrosis Using a New Dry Powder Inhaler Device

Sandra D Anderson

The Open Respiratory Medicine Journal, 2014

View PDFchevron_right

The Impact of Flow rate on Inhaler Dose Delivery from a Dry Powder Inhaler using a Two Stage Impinger

Huner Omer

ZANCO JOURNAL OF PURE AND APPLIED SCIENCES, 2018

View PDFchevron_right

Clinically Relevant In Vitro Performance Tests for Powder Inhalers

Xiangyin Wei

2016

View PDFchevron_right

Comparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhaler

David Geller

Respiratory care, 2005

View PDFchevron_right

Sensitivity And Specificity Of An Acoustic Method For Calculating Peak Inspiratory Flow Rate And Inspiratory Volume Through A Diskus Dry Powder Inhaler

E. Machale

View PDFchevron_right

Establishment of relationships between native and inhalation device specific spirometric parameters as a step towards patient tailored inhalation device selection

Szilvia Kugler

Respiratory Medicine, 2019

View PDFchevron_right

Suboptimal Inspiratory Flow Rates With Passive Dry Powder Inhalers: Big Issue or Overstated Problem?

Jeffry Weers

Frontiers in Drug Delivery

View PDFchevron_right

Clickhaler (a Novel Dry Powder Inhaler) Provides Similar Bronchodilation to Pressurized Metered-Dose Inhaler, Even at Low Flow Rates*

Carole Chambers

CHEST Journal, 1999

View PDFchevron_right

In vitro dose comparison of Respimat® inhaler with dry powder inhalers for COPD maintenance therapy

herbert wachtel

International Journal of Chronic Obstructive Pulmonary Disease, 2017

View PDFchevron_right

Goals of Inhalation Therapy Dry Powder Inhalers DPI Use During Mechanical Ventilation

Rajiv Dhand

2015

View PDFchevron_right

Experimental Lung Research Total emitted dose of salbutamol sulphate at different inhalation flows and inhalation volumes through different types of dry powder inhalers

Ahmed A Elberry

View PDFchevron_right

The ELLIPTA(®) Dry Powder Inhaler: Design, Functionality, In Vitro Dosing Performance and Critical Task Compliance by Patients and Caregivers

Melanie Hamilton

Journal of aerosol medicine and pulmonary drug delivery, 2015

View PDFchevron_right

Effects of Device and Formulation on In Vitro Performance of Dry Powder Inhalers

Bill Doub

The AAPS Journal, 2012

View PDFchevron_right